Biomeme, Inc.
Philadelphia, PA
- UEI
- WKMXPY532T54
- CAGE
- 6YZ39
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 401 N Broad St Suite 222, Philadelphia, PA 19108, USA
- Website
- biomeme.com
- Founded
- 2012
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $0 |
| FY2025 | $0 |
| FY2024 | $44,725 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Contract subawards
| Prime contractor | Prime award | Amount | Awarded |
|---|---|---|---|
| Atlantic Diving Supply, Inc. | 47QFNA25F0021 | $366,300 | |
| The Johns Hopkins University Applied Physics Laboratory LLC | N0002423F8199 | $48,600 | |
| The Johns Hopkins University Applied Physics Laboratory LLC | N0002423F8199 | $48,600 |
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of assay panel for vector-borne disease | Interior Business Center (DO) | $3,238,339 |
Similar vendors
About the company
Biomeme, Inc. is a manufacturer of innovative molecular diagnostic solutions and products, specializing in mobile lab systems that transform smartphones into advanced DNA diagnostic devices. The company provides real-time PCR thermocyclers, custom reagents, and assay delivery to various U.S. federal government agencies, including the Department of Defense, Department of Agriculture, and Department of Commerce. Registered as a self-certified small disadvantaged business and for-profit organization in the System for Award Management (SAM.gov), Biomeme designs and produces products for rapid, accurate, and portable molecular testing across a wide range of applications, including infectious disease detection, environmental monitoring, and biothreat identification.
Through federal contract awards, Biomeme has supplied a variety of goods and services to government agencies. These include the provision of Franklin Real-Time PCR Thermocyclers, custom Go-Strips, mosquito-borne pathogen testing kits, tick surveillance kits, and other specialized diagnostic equipment. The company has received purchase orders and delivery orders from agencies such as the Navy's Bureau of Medicine and Surgery, Army's Joint PEO Chemical and Biological Defense, Air Force Materiel Command, and the National Oceanic and Atmospheric Administration. Notable contracts include a $1.12 million delivery order for assay delivery and program management support of the Final Form Configuration System for the Chemical and Biological Defense program. As a subcontractor, Biomeme has provided materials, supplies, reagents, hardware, and other products to prime contractors like MRIGlobal, UES Inc., and Johns Hopkins University Applied Physics Laboratory. Most of Biomeme's contract awards have been without set-aside designations, although they have received at least one award under a Total Small Business set-aside.
Regarding federal grant awards, Biomeme has not directly received prime grants from federal agencies. However, the company has participated as a subrecipient in federally funded research projects. Notably, Biomeme has provided research and development support under a National Institutes of Health (NIH) grant awarded to Duke University. This project focused on developing and validating host gene expression tests on Biomeme's Franklin integrated sample processing platform for the detection of viral infections, including presymptomatic cases, and the discrimination between bacterial and viral infections. The work involved developing the Franklin-ISP platform to meet requirements for host gene expression-based tests, creating and validating specific tests for viral and bacterial infections, and engaging with the FDA to define requirements for regulatory clearance. This subgrant demonstrates Biomeme's capability to contribute to cutting-edge research in molecular diagnostics and infectious disease detection, leveraging their expertise in portable PCR technology.
SBA capabilities narrative
Biomeme, Inc. develops and markets innovative mobile real-time qPCR systems for advanced DNA diagnostics for point-of-need (PON) clinicians and epidemiologists identifying, tracking and developing strategies to combat global pathogens and diseases.
Quick answers
Is Biomeme, Inc. registered in SAM.gov?
Yes. Biomeme, Inc.'s SAM.gov registration is active through June 24, 2027.
How much has Biomeme, Inc. received in federal contracts?
Federal contracts obligated $44,725 to Biomeme, Inc. in fiscal years 2023 through 2027.
What is Biomeme, Inc.'s most recent federal award?
Biomeme, Inc.'s most recent federal contract award is Biomeme SKU 1000003R black franklin thre (N3239824P0019), from Bureau of Medicine and Surgery (Navy), on May 23, 2024.
On GovTribe
See Biomeme, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors